Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-001276
Filing Date
2022-01-06
Accepted
2022-01-06 20:27:03
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7530
  Complete submission text file 0000899243-22-001276.txt   10240
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-254-4445
Vigil Neuroscience, Inc. (Issuer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105
Business Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105 (424) 313-1550
Vida Ventures GP III, L.L.C. (Reporting) CIK: 0001855502 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41200 | Film No.: 22516257

Mailing Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105
Business Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105 (424) 313-1550
Vida Ventures III-A, L.P. (Reporting) CIK: 0001855503 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41200 | Film No.: 22516255

Mailing Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105
Business Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105 (424) 313-1550
Vida Ventures III, L.P. (Reporting) CIK: 0001855504 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41200 | Film No.: 22516256